Amrutanjan Health Care Limited has announced the rephrasing of the Second Phase ESOP 2 of its existing Employee Stock Option Scheme 2020. The company communicated this development to stock exchanges on April 17, 2026, in compliance with regulatory requirements.

Committee Approval and Regulatory Compliance

The rephrasing decision received approval from the company's Nomination and Remuneration Committee/Compensation Committee through a resolution passed on April 17, 2026. The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with applicable circulars issued by SEBI.

ESOP Scheme Details

Corporate Communication

The formal intimation was signed by Gagan Preet Singh, General Manager - Legal, Company Secretary & Compliance Officer, and submitted to both the National Stock Exchange of India Limited and BSE Limited. The company has requested the exchanges to take the information on record and acknowledge receipt.

Company Background

Amrutanjan Health Care Limited, established in 1893, operates from its registered office at Luz Church Road, Mylapore, Chennai. The company trades on NSE under the symbol AMRUTANJAN and on BSE with scrip code 590006, with ISIN INE098F01031.

Amrutanjan health care Limited has submitted its quarterly compliance certificate under SEBI (Depository Participants) Regulations for the quarter ended 31/03/2026. The filing was made on April 08, 2026, to both the National Stock Exchange of India Limited and BSE Limited, demonstrating the company's commitment to regulatory compliance.

Regulatory Compliance Details

The compliance certificate was submitted pursuant to Regulation 74(5) of the SEBI (Depository Participants) Regulation, 2018. The certificate was issued by Cameo Corporate Services Limited, which serves as the company's Registrar and Share Transfer Agents.

Certificate Confirmation

Cameo Corporate Services Limited confirmed that securities received from depository participants for dematerialisation during the quarter ended 31st March 2026 were properly processed. The registrar verified that all securities were confirmed to the depositories and that the securities comprised in the certificates have been listed on stock exchanges where the company's earlier issued securities are traded.

The certificate also confirms that security certificates received for dematerialisation were mutilated and cancelled after due verification by the depository participant. Additionally, the names of the depositories have been substituted in the register of members as the registered owner within the stipulated time limit under the captioned regulations.

Corporate Communication

The compliance filing was signed by Gagan Preet Singh, General Manager - Legal, Company Secretary & Compliance Officer of Amrutanjan Health Care Limited. The communication was addressed to both major stock exchanges where the company's shares are listed, ensuring comprehensive regulatory disclosure.

This quarterly compliance certificate submission reflects the company's ongoing adherence to SEBI regulations governing depository participants and securities dematerialisation processes.